SCHEMBL2044819

SCHEMBL2044819

C1=Nc2c3c(ccc2=C1)=NC=N3

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8121239 0.79
SCHEMBL2042594 0.73
SCHEMBL10935478 0.69
SCHEMBL585661 0.68
SCHEMBL2045014 0.64
SCHEMBL2043075 0.64
SCHEMBL9050545 0.62
SCHEMBL4756368 0.60
SCHEMBL6533764 0.60
SCHEMBL3726275 0.59

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 50 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2336315-B1 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION AS (DK) 2017-07-19 EP claimed
EP-2336315-A2 Enzymatic encoding methods for efficient synthesis of large libraries Nuevolution A/S (DK) 2011-06-22 EP claimed
US-11702652-B2 Enzymatic encoding methods for efficient synthesis of large libraries NUEVOLUTION A/S (DK) 2023-07-18 US disclosed
CN-115894534-A Polycyclic aromatic compound, material for organic device, organic electroluminescent element, display device, and lighting device 学校法人关西学院 2023-04-04 CN disclosed
US-20230032216-A1 INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AND RESPECTIVE METABOLITES AS BIOMARKERS FOR CANCER Deutsches Krebsforschungszentrum Stiftung des oeffentlichen Rechts Im Neuenheimer Feld 280 (DE) 2023-02-02 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-114901837-A Interleukin-4 inducible gene 1(IL4I1) and corresponding metabolites as biomarkers for cancer 德国癌症研究公共权益基金会 2022-08-12 CN disclosed
US-20220195533-A1 ARYL HYDROCARBON RECEPTOR (AHR) ACTIVATION SIGNATURE AND METHODS FOR DETERMINING AHR SIGNALING STATUS DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OFFENTLICHEN RECHTS (DE) 2022-06-23 US disclosed
US-20220170096-A1 INTERLEUKIN-4-INDUCED GENE 1 (IL4I1) AS A BIOMARKER AND USES THEREOF DEUTSCHES KREBSFORSCHUNGSZENTRUM STIFTUNG DES OEFFENTLICHEN RECHTS (DE) 2022-06-02 US disclosed
CN-114127311-A Arene receptor (AHR) activation profile and methods for determining AHR signaling status 德国癌症研究公共权益基金会 2022-03-01 CN disclosed
CN-114126634-A Interleukin-4 inducible gene 1(IL4I1) as biomarker and use thereof 德国癌症研究公共权益基金会 2022-03-01 CN disclosed
WO-2007062664-A2 ENZYMATIC ENCODING METHODS FOR EFFICIENT SYNTHESIS OF LARGE LIBRARIES NUEVOLUTION A/S (DK) 2007-06-07 WO disclosed
US-4863930-A Use of substituted 5H-pyrido- and 5H-thiazolo(2',1':2,3)imidazo (4,5-b)indoles as cholinomimetic agents ADHIKARY PARIMAL K (US) 1989-09-05 US disclosed
EP-0273663-A2 Substituted 5H-pyrido- and 5H-thiazolo[2',1':2,3]imidazo[4,5-b]indoles and their use as cholinomimetic agents Adhikary, Parimal K. (US) 1988-07-06 EP disclosed
US-4255573-A Imidazoindole derivatives and pharmaceutical compositions comprising imidazoindole derivatives ADHIKARY PARIMAL K 1981-03-10 US disclosed
US-4255573-A Imidazoindole derivatives and pharmaceutical compositions comprising imidazoindole derivatives ADHIKARY PARIMAL K 1981-03-10 US disclosed
US-4204067-A Derivatives of imidazo[2,1-b] thiazole ADHIKARY PARIMAL K 1980-05-20 US disclosed
US-4160840-A Derivatives of imidazoindole and imidazothiazole ADHIKARY PARIMAL K 1979-07-10 US disclosed
US-4160840-A Derivatives of imidazoindole and imidazothiazole ADHIKARY PARIMAL K 1979-07-10 US disclosed
US-4143142-A NOVEL PYRIDO-IMIDAZO-INDOLES, COMPOSITIONS AND METHOD THEREWITH ADHIKARY PARIMAL K 1979-03-06 US disclosed